MALAT1 and breast carcinoma: Using the Malat1 knock-out (KO) mouse model developed by Nakagawa et al. (LacZ and Poly-A sequences were used as transcriptional terminators inserted 69 bp downstream of the transcription start site of Malat1 without deletion of the DNA sequence), Kim et al. crossed these mice with a breast cancer model driven by MMTV-PyMT that mimics human disease.